drugset / Trial / NCT00644280
Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether ranibizumab therapy before and after tube insertion for glaucoma surgeries can maintain the patency of the tube and prevent scar formation, and increase the chances for a successful procedure compared to observation.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-12
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |